In accordance with the percentages of CD184+ visASCs described by flow cytometry, the number of visASCs attracted by the SDF1α toward the bottom surface of the migration chamber was higher in MS subjects (Fig 3A). The gene discussed is CXCL12; the disease is myeloid sarcoma.